About Ultrasound AI
Ultrasound AI is a medical AI company that has developed Delivery Date AI™, an FDA De Novo-granted cloud-based Software as a Medical Device (SaMD) designed to support obstetric care through AI-powered delivery date prediction. The company's flagship product analyzes standard pregnancy ultrasound images to provide clinicians with an independent Predicted Delivery Date (PDD) for singleton pregnancies between 14 0/7 and 36 6/7 weeks gestation where a reliable estimated delivery date is unavailable. Founded by Robert Bunn, the company was built on the principle that every family deserves clarity and confidence during pregnancy. Delivery Date AI addresses a critical gap in prenatal care: approximately 24.5% of US pregnancies do not begin prenatal care in the first trimester, and 35% of US counties are maternity care deserts. The technology has been clinically validated across more than 5,700 patients in peer-reviewed studies, demonstrating a 58% reduction in prediction error compared to standard of care methods. The solution integrates seamlessly into existing clinical workflows, requiring no new hardware and delivering results in under 30 seconds through a HIPAA-compliant cloud infrastructure. Ultrasound AI's technology is designed as an adjunctive tool to support clinical judgment, not replace it, providing OB/GYNs and MFM specialists with an additional reliable data point when standard dating methods fall short due to unreliable last menstrual period, absence of first-trimester scans, or late presentation to care.
Mission & Story
Mission
Every family deserves clarity and confidence during pregnancy
Founding Story
Founded by Robert Bunn, who has shared the personal story behind Delivery Date AI in media interviews. Built by technologists and clinicians with experience in AI, data science, and software engineering, turning complex imaging data into clear, clinically useful insights.
Clinical Focus
Medical conditions and clinical areas addressed by Ultrasound AI.
Who It Serves
Milestones & Awards
Recent Milestones
FDA De Novo authorization granted March 2026. Expanded U.S. commercial deployment preparation underway. Multiple media features in 2026 including CBS News Colorado, The Healthcast, and The Healthtech Podcast.
Awards & Recognition
2023 Geneva Innovation Award Winner for innovation and clinical impact
Key Partnerships
Company Details
- Headquarters
- Greenwood Village, CO, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.